Wiggin and Dana Announces Attorney Promotions

January 3, 2012

NEW HAVEN – Wiggin and Dana is pleased to announce a partner and two counsel promotions effective January 1, 2012.

David Schaffer, Partner, is a member of the firm's Corporate Practice Department. He is resident in the firm's Stamford office. David represents publicly-traded and privately-held companies on a broad range of corporate and commercial matters, including mergers, acquisitions and divestitures, joint ventures and other strategic transactions, private equity and venture capital financings, entity formation and restructuring, securities law compliance and corporate governance. He has experience in domestic and cross-border transactions that cover a variety of industry sectors, including information technology, financial services, manufacturing, outsourcing, biotechnology and health care services. As part of his international practice, David regularly assists European, Indian and Chinese clients conduct business in the U.S.

James Craven, Counsel, is a member of the firm's Litigation Department. He is resident in the firm's New Haven office. He has significant experience in resolving complicated disputes through mediation, arbitration, and litigation. His diverse practice includes representing clients in commercial disputes, product liability claims, complex personal injury and professional malpractice matters, tax appeals, and toxic torts.

William Kilgallen, Counsel, is a member of the firm's Corporate Practice Department. He is resident in the firm's New Haven office. His practice focuses on the representation of emerging growth companies with respect to venture capital financing transactions, loan transactions and mergers and acquisitions. Bill advises both private and public companies on a wide array of financings which include equity, debt and convertible debt, as well as PIPEs. Bill also advises the firm's clients on a variety of derivative transactions. In addition, Bill advises companies regarding compliance with various laws and regulations which impact their ability to raise funds, such as the Securities Act, the Securities Exchange Act, Sarbanes-Oxley, Reg. FD and rules promulgated by the NYSE, AMEX, NASDAQ and the FINRA.